Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation

ME03132BActive Publication Date: 2019-04-20CHIESI FARMACEUTICI SPA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
ME2018273
Authority / Receiving Office
ME · ME
Patent Type
Patents
Current Assignee / Owner
Priority Date
2014-07-10
Filing Date
2014-07-10
Publication Date
2019-04-20
Estimated Expiration
2034-07-10
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.